Regulation (EU) 2017/746
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )
In forceTyperegulationDate5 Apr 2017Since1 Jan 2017Articles114Versions held192Cited by190 documentsLast changed10 Jan 2025
- 5Placing on the market and putting into service
- 6Distance sales
- 7Claims
- 8Use of harmonised standards
- 9Common specifications
- 10General obligations of manufacturers
- 10aObligations in case of interruption or discontinuation of supply of certain devices
- 11Authorised representative
- 12Change of authorised representative
- 13General obligations of importers
- 14General obligations of distributors
- 15Person responsible for regulatory compliance
- 16Cases in which obligations of manufacturers apply to importers, distributors or other persons
- 17EU declaration of conformity
- 18CE marking of conformity
- 19Devices for special purposes
- 20Parts and components
- 21Free movement
- 22Identification within the supply chain
- 23Medical devices nomenclature
- 24Unique Device Identification system
- 25UDI database
- 26Registration of devices
- 27Electronic system for registration of economic operators
- 28Registration of manufacturers, authorised representatives and importers
- 29Summary of safety and performance
- 30European database on medical devices
- 31Authorities responsible for notified bodies
- 32Requirements relating to notified bodies
- 33Subsidiaries and subcontracting
- 34Application by conformity assessment bodies for designation
- 35Assessment of the application
- 36Nomination of experts for joint assessment of applications for notification
- 37Language requirements
- 38Designation and notification procedure
- 39Identification number and list of notified bodies
- 40Monitoring and re-assessment of notified bodies
- 41Review of notified body assessment of technical documentation and performance evaluation documentation
- 42Changes to designations and notifications
- 43Challenge to the competence of notified bodies
- 44Peer review and exchange of experience between authorities responsible for notified bodies
- 45Coordination of notified bodies
- 46List of standard fees
Section 2 Conformity assessment
- 48Conformity assessment procedures
- 49Involvement of notified bodies in conformity assessment procedures
- 50Mechanism for scrutiny of conformity assessments of class D devices
- 51Certificates of conformity
- 52Electronic system on notified bodies and on certificates of conformity
- 53Voluntary change of notified body
- 54Derogation from the conformity assessment procedures
- 55Certificate of free sale
- 56Performance evaluation and clinical evidence
- 57General requirements regarding performance studies
- 58Additional requirements for certain performance studies
- 59Informed consent
- 60Performance studies on incapacitated subjects
- 61Performance studies on minors
- 62Performance studies on pregnant or breastfeeding women
- 63Additional national measures
- 64Performance studies in emergency situations
- 65Damage compensation
- 66Application for performance studies
- 67Assessment by Member States
- 68Conduct of a performance study
- 69Electronic system on performance studies
- 70Performance studies regarding devices bearing the CE marking
- 71Substantial modifications to performance studies
- 72Corrective measures to be taken by Member States and information exchange between Member States on performa
- 73Information from the sponsor at the end of a performance study or in the event of a temporary halt or early
- 74Coordinated assessment procedure for performance studies
- 75Review of the coordinated assessment procedure
- 76Recording and reporting of adverse events that occur during performance studies
- 77Implementing acts
Section 1 Post-market surveillance
- 88Market surveillance activities
- 89Evaluation of devices suspected of presenting an unacceptable risk or other non-compliance
- 90Procedure for dealing with devices presenting an unacceptable risk to health and safety
- 91Procedure for evaluating national measures at Union level
- 92Other non-compliance
- 93Preventive health protection measures
- 94Good administrative practice
- 95Electronic system on market surveillance
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).